| __timestamp | ACADIA Pharmaceuticals Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 1499100000 |
| Thursday, January 1, 2015 | 90804000 | 1923500000 |
| Friday, January 1, 2016 | 186456000 | 2351400000 |
| Sunday, January 1, 2017 | 255062000 | 2564000000 |
| Monday, January 1, 2018 | 265758000 | 2397300000 |
| Tuesday, January 1, 2019 | 325638000 | 2503400000 |
| Wednesday, January 1, 2020 | 388661000 | 3344600000 |
| Friday, January 1, 2021 | 396028000 | 4529200000 |
| Saturday, January 1, 2022 | 369090000 | 4179100000 |
| Sunday, January 1, 2023 | 402466000 | 4650100000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Viatris Inc. and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Over this period, Viatris Inc. consistently outpaced ACADIA Pharmaceuticals in SG&A spending, with expenses peaking at approximately $4.65 billion in 2023, a staggering 210% increase from 2014. In contrast, ACADIA Pharmaceuticals saw a more modest rise, with expenses growing by about 1,130% over the same period, reaching around $402 million in 2023. This disparity highlights Viatris's expansive operational scale compared to ACADIA's more focused approach. As the industry continues to grow, these trends offer valuable insights into each company's strategic priorities and market positioning.
Selling, General, and Administrative Costs: Sanofi vs ACADIA Pharmaceuticals Inc.
Bristol-Myers Squibb Company or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Viatris Inc. vs Summit Therapeutics Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Viatris Inc. and Insmed Incorporated
Who Optimizes SG&A Costs Better? Viatris Inc. or Madrigal Pharmaceuticals, Inc.
Viatris Inc. vs Exelixis, Inc.: SG&A Expense Trends
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Viatris Inc. and Geron Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Viatris Inc. and Evotec SE
Rhythm Pharmaceuticals, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.